Intech Investment Management LLC Reduces Stock Holdings in Masimo Corporation $MASI

Intech Investment Management LLC trimmed its holdings in shares of Masimo Corporation (NASDAQ:MASI) by 16.6% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 24,765 shares of the medical equipment provider’s stock after selling 4,925 shares during the quarter. Intech Investment Management LLC’s holdings in Masimo were worth $3,221,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the business. Jupiter Asset Management Ltd. acquired a new stake in Masimo during the 3rd quarter worth about $12,491,000. American Century Companies Inc. lifted its position in Masimo by 10.6% during the 3rd quarter. American Century Companies Inc. now owns 168,341 shares of the medical equipment provider’s stock worth $24,839,000 after acquiring an additional 16,113 shares during the period. ING Groep NV acquired a new stake in Masimo during the 3rd quarter worth about $3,069,000. Citigroup Inc. lifted its position in Masimo by 133.5% during the 3rd quarter. Citigroup Inc. now owns 116,672 shares of the medical equipment provider’s stock worth $17,215,000 after acquiring an additional 66,710 shares during the period. Finally, Massachusetts Financial Services Co. MA lifted its position in Masimo by 1.7% during the 4th quarter. Massachusetts Financial Services Co. MA now owns 2,663,875 shares of the medical equipment provider’s stock worth $346,464,000 after acquiring an additional 43,915 shares during the period. 85.96% of the stock is currently owned by hedge funds and other institutional investors.

Masimo Stock Performance

NASDAQ MASI opened at $178.59 on Tuesday. The stock has a market capitalization of $9.35 billion, a price-to-earnings ratio of -16.94, a PEG ratio of 1.81 and a beta of 1.11. Masimo Corporation has a twelve month low of $125.94 and a twelve month high of $179.00. The company has a current ratio of 2.68, a quick ratio of 1.45 and a debt-to-equity ratio of 0.56. The stock has a 50-day moving average of $178.41 and a 200 day moving average of $158.60.

Analyst Upgrades and Downgrades

A number of brokerages have commented on MASI. Stifel Nicolaus set a $180.00 price target on Masimo in a research report on Tuesday, February 17th. Raymond James Financial cut Masimo from an “outperform” rating to a “market perform” rating in a report on Friday, March 27th. BTIG Research cut Masimo from a “buy” rating to a “neutral” rating in a report on Wednesday, February 18th. Piper Sandler cut Masimo from an “overweight” rating to a “hold” rating and set a $180.00 price objective for the company. in a report on Tuesday, February 17th. Finally, Wolfe Research cut Masimo from a “strong-buy” rating to a “hold” rating in a report on Thursday, February 19th. Nine equities research analysts have rated the stock with a Hold rating, According to data from MarketBeat, the company presently has an average rating of “Hold” and an average price target of $180.40.

Masimo Company Profile

Masimo (NASDAQ: MASI) is a global medical technology company specializing in noninvasive monitoring solutions. The company’s flagship technology, Masimo SET® (Signal Extraction Technology), enhances the accuracy of pulse oximetry in challenging clinical conditions. Beyond pulse oximetry, Masimo’s portfolio extends to brain function monitoring, regional oximetry, and acoustic respiration rate monitoring, serving critical, acute, and ambulatory care settings.

In addition to its core monitoring technologies, Masimo offers a range of patient cables, sensors, and connectivity platforms designed to integrate with hospital information systems and remote monitoring applications.